Skip to main content
Log in

Frequency, pathogenicity and microbiologic outcome of non-Candida albicans candiduria

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

A retrospective review of urine cultures obtained from patients at the University of Illinois Hospital revealed that the frequency of isolation of non-albicans Candida species increased significantly from 1990 to 1991 (p=0.0003), while the frequency of isolation ofCandida albicans species decreased significantly (p=0.0006). Patients with urine cultures positive for non-albicans Candida species orTorulopsis glabrata during 1991 were identified for review. Sixty-seven patients were eligible for evaluation. Non-albicans candiduria developed in an average of 12 days. Identical fungal species were isolated from the blood following a positive urine culture in only two patients. Twenty patients were treated; candiduria persisted in 9 (45 %), while resolution occurred in 11 (55 %). The remaining 47 patients were not treated. Non-albicans candiduria persisted in 30 (64 %) of these patients and resolved in 15 (32 %); in the remaining two patients (4 %) the microbiologic outcome was undetermined. The difference in microbiologic outcomes between treated and untreated patients was not significant using the Chi-square test (p=0.170). Non-albicans candiduria developed rapidly, frequently persisted whether treated or untreated, and rarely progressed to candidemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schaberg DR, Culver DH, Gaynes RP: Major trends in the microbial etiology of nosocomial infection. American Journal of Medicine 1991, 91, Supplement 3B: 72–75.

    Article  Google Scholar 

  2. Michigan S: Genitourinary fungal infections. Journal of Urology 1976, 116: 390–397.

    PubMed  Google Scholar 

  3. Rivett AG, Perry JA, Cohen J: Urinary candidiasis: a prospective study in hospital patients. Urological Research 1986, 14: 183–186.

    Article  PubMed  Google Scholar 

  4. Haley LD: Yeast infections of the lower urinary tract: in vitro studies of the tissue phase of Candida albicans. Sabouraudia 1965, 4: 98–105.

    PubMed  Google Scholar 

  5. Frye KR, Donovan JM, Drach GW:Torulopsis glabrata urinary infections: a review. Journal of Urology 1988, 139: 1245–1249.

    PubMed  Google Scholar 

  6. Merz WG:Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. Journal of Clinical Microbiology 1984, 20: 1194–1195.

    PubMed  Google Scholar 

  7. Baker JG, Nadler HL, Forgacs P, Kurtz SR:Candida lusitaniae: a new opportunistic pathogen of the urinary tract. Diagnostic Microbiology and Infectious Diseases 1984, 2: 145–149.

    Article  Google Scholar 

  8. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R: The value of fungal surveillance cultures as predictors of systemic fungal infections. Journal of Infectious Diseases 1980, 142: 503–509.

    PubMed  Google Scholar 

  9. Wingard JR, Merz WG, Saral R:Candida tropicalis: a major pathogen in immunocompromised patients. Annals of Internal Medicine 1979, 91: 539–543.

    PubMed  Google Scholar 

  10. Hamory BH, Wenzel RP: Hospital-associated candiduria: predisposing factors and review of the literature. Journal of Urology 1978, 120: 444–448.

    PubMed  Google Scholar 

  11. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP: Risk factors for hospital-acquired candidemia: a matched case-control study. Archives of Interinal Medicine 1989, 149: 2349–2353.

    Article  Google Scholar 

  12. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL: Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. American Journal of Medicine 1989, 87: 614–620.

    PubMed  Google Scholar 

  13. Hasenclaver HF, Mitchell WD: Pathogenicity ofC. albicans andC. tropicalis. Sabouraudia 1961, 1: 16–21.

    PubMed  Google Scholar 

  14. Hasenclaver HF, Mitchell WD: Pathogenesis ofTorulopsis glabrata in physiologically altered mice. Sabouradia 1963, 2: 271–283.

    Google Scholar 

  15. Wingard JR, Dick JD, Merz WG, Sandford GR, Saral R, Burns WH: Differences in virulence of clinical isolates ofCandida tropicalis andCandida albicans in mice. Infection and Immunity 1982, 37: 833–836.

    PubMed  Google Scholar 

  16. Fromtling RA, Abruzzo GK, Giltinan DM:Candida tropicalis infection in normal, diabetic, and neutropenic mice. Journal of Clinical Microbiology 1987, 25: 1416–1420.

    PubMed  Google Scholar 

  17. Kozinn PJ, Paschdjian CL, Goldberg PK, Wise GJ, Toni EF, Seelig MS: Advances in the diagnosis of renal candidiasis. Journal of Urology 1978, 119: 184–187.

    PubMed  Google Scholar 

  18. Wise GJ, Goldberg P, Kozinn PJ: Genitourinary candidiasis: diagnosis and treatment. Journal of Urology 1976, 116: 778–780.

    PubMed  Google Scholar 

  19. Goldberg PK, Kozinn PJ, Wise GJ, Nouri N, Brooks RB: Frequency and significance of candiduria. Journal of the American Medical Association 1979, 241: 582–584.

    Article  PubMed  Google Scholar 

  20. Wise GJ, Kozinn PJ, Goldberg P: Amphotericin B as a urologic irrigant in the management of noninvasive candiduria. Journal of Urology 1982, 128: 82–84.

    PubMed  Google Scholar 

  21. Fong IW, Chang PC, Hinton NA: Fungicidal effect of amphotericin B in urine: in vitro study to assess feasibility of bladder washout for site of candiduria. Antimicrobial Agents and Chemotherapy 1991, 35: 1856–1859.

    PubMed  Google Scholar 

  22. Pappagianis D, Collins MS, Hector R, Remington J: Development of resistance to amphotericin B inCandida lusitaniae infecting a human. Antimicrobial Agents and Chemotherapy 1979, 16: 123–126.

    PubMed  Google Scholar 

  23. Fisher JF, Hicks BC, DiPiro JT, Venable J, Fincher RE: Efficacy of a single intravenous dose of amphotericin B in urinary tract infections caused byCandida. Journal of Infectious Diseases 1987, 156: 685–687.

    PubMed  Google Scholar 

  24. Dermoumi H: In vitro susceptibilities of yeast isolates from the blood to fluconazole and amphotericin B. Chemotherapy 1992, 38: 112–117.

    PubMed  Google Scholar 

  25. Warnick DW, Burke J, Cope NJ, Johnson EM, Von Fraunhofer NA, Williams EW: Fluconazole resistance inCandida glabrata. Lancet 1988, ii: 1310.

    Article  Google Scholar 

  26. Shiba K, Saito A, Miyahara T: Safety and pharmacokinetics of single and oral intravenous doses of fluconazole in healthy subjects. Clinical Therapeutics 1990, 12: 206–215.

    PubMed  Google Scholar 

  27. Persons DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW: Fluconazole andCandida kruseii fungemia. New England Journal of Medicine 1991, 325: 1315.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Occhipinti, D.J., Gubbins, P.O., Schreckenberger, P. et al. Frequency, pathogenicity and microbiologic outcome of non-Candida albicans candiduria. Eur. J. Clin. Microbiol. Infect. Dis. 13, 459–467 (1994). https://doi.org/10.1007/BF01974635

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01974635

Keywords

Navigation